Atarax and Sovaldi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atarax (hydroxyzine hydrochloride) and Sovaldi (sofosbuvir). Common drug interactions include pulmonary arterial hypertension among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Atarax and Sovaldi. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Atarax?

Atarax has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 23,553 Atarax users. Check the latest studies of Atarax.

What is Sovaldi?

Sovaldi has active ingredients of sofosbuvir. eHealthMe is studying from 12,697 Sovaldi users. Check the latest studies of Sovaldi.



On Jul, 30, 2026

18 people who take Atarax and Sovaldi together, and have interactions are studied.

Atarax and Sovaldi drug interactions.

What are the common drug interactions of Atarax and Sovaldi, by gender? *:

female:

  1. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  2. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  3. Anaemia (lack of blood)
  4. Asthenia (weakness)
  5. Chest pain
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Hypotension (abnormally low blood pressure)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)

male:

  1. Anaemia (lack of blood)
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Fatigue (feeling of tiredness)
  4. Gingival swelling (gums swelling)
  5. Headache (pain in head)
  6. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  7. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  10. Skin disorder (skin disease)

What are the common drug interactions of Atarax and Sovaldi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood creatine phosphokinase increased
  2. Myalgia (muscle pain)
  3. Arthralgia (joint pain)
  4. Hypoaesthesia (reduced sense of touch or sensation)

40-49:

  1. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

50-59:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Burning sensation
  4. Deafness
  5. Ear disorder
  6. Facial paresis (weakness in facial muscle movement)
  7. Fatigue (feeling of tiredness)
  8. Gingival swelling (gums swelling)
  9. Headache (pain in head)
  10. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)

60+:

  1. Anaemia (lack of blood)
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  5. Hepatocellular carcinoma (liver cancer)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Asthenia (weakness)
  8. Chest pain
  9. Dizziness
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Hepatitis C: 12 people, 66.67%
  2. Oedema Peripheral (superficial swelling): 4 people, 22.22%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 11.11%
  4. Sleep Disorder: 1 person, 5.56%
  5. Seasonal Allergy (allergic condition due to certain season): 1 person, 5.56%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 5.56%
  7. Insomnia (sleeplessness): 1 person, 5.56%
  8. Hiv Infection: 1 person, 5.56%
  9. Hepatitis C Virus Test Positive: 1 person, 5.56%
  10. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Atarax and Sovaldi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atarax and Sovaldi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atarax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sovaldi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atarax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sovaldi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydroxyzine hydrochloride and sofosbuvir (the active ingredients of Atarax and Sovaldi, respectively), and Atarax and Sovaldi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: